A supplier change notice can affect your product in ways that aren't obvious at first. This 60-minute webinar on impact assessments for supplier change notices presents strategies and tools for evaluating them thoroughly.
You'll learn how to decide whether a notice needs a full impact assessment and when lower-impact changes can be accepted or rejected without one. The session covers who should sit on the impact assessment team, which skill sets they need, how often to meet and how to evaluate notices, including verification and validation of the change.
It also highlights supplier and quality agreements with vendors, risk-based approaches to assessment, what happens if a change is unacceptable and how to set up incoming material specifications.
Pharmaceutical and medical device manufacturers are responsible for the quality and source of every incoming material. If a supplier change isn't evaluated properly, it can cause failed manufacturing runs or nonconforming product reaching the market, and FDA expects manufacturers to control incoming materials, so poor assessments can lead to enforcement action or recalls.
The session suits QA, regulatory affairs and supply chain professionals, technical scientists and production staff.
Pharmaceutical and medical device manufacturers are responsible for the quality and source of every incoming material. If a supplier change isn't evaluated properly, it can cause failed manufacturing runs or nonconforming product reaching the market, and FDA expects manufacturers to control incoming materials, so poor assessments can lead to enforcement action or recalls.
The session suits QA, regulatory affairs and supply chain professionals, technical scientists and production staff.
Alan M Golden
Alan M Golden has over 30 years of experience in the medical device industry, both in basic research and quality assurance. Alan spent 31 years at Abbott Laboratories. For the first 16 years as part of diagnostics R&D, he developed recombinant proteins used in diagnostics tests, received three US patents, and published numerous papers and abstracts. Alan then transitioned to a quality assurance role wherein both the Abbott Diagnostics and Abbott Molecular divisions, he was responsible for quality assurance for new product development, on-market product support, and operations.Alan’s quality assurance experience extends from design control, change control, risk …
New Form I-9: Documents and Policies that Ensure ICE I-9 Co…
Claude AI For CPAs & Finance Professionals: Best Practices …
Secrets Of Psychology - Why People Do The Things They Do
2-Hour Virtual Seminar on How to Conduct an Internal Harass…
Project Management For Administrative Professionals
Onboarding is NOT Orientation - How to Improve the New Empl…
Elevate Your Workplace Wellness: 10 Critical Wellness Facto…
Managing Complex Projects - Project Management
Utilizing HR Metrics to Illustrate & Improve Human Resource…
Negotiating Skills For Professional Results - Winning Strat…
NEW Nacha Rule - Third-Party Sender (TPS) Roles and Respons…
Paying and Receiving Payments for Referrals: You Can Go to …
FDA Technology Modernization Action Plan (TMAP) and Impact …
Human Factors Usability Studies Following ISO 62366 and FDA…
Construction Lending And Real Credit Administration: Evalua…
Validation Statistics for Non-Statisticians
Thriving in a Hybrid Workplace: Keys to Leadership and Team…
Excel Power Skills: Master Functions, Formulas, and Macros …
Batch Record Review and Product Release
Discover how Emotional Intelligence turns AI from a technic…
Copilot and HR: An Introduction for HR Professionals
ChatGPT for HR - Build HR Policy Framework and Strategy
Female to Female Hostility @Workplace: All you Need to Know